ADAPY
Adaptimmune Therapeutics plc
OTC Markets OTCPKUSDEQUITY
Healthcare
DELAYED
Buy
+44/100
Last price
0.03
▼ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.03
Prev close
0.03
Day high
0.03
Day low
0.02
Volume
17.27K
Market cap
$7.69M
P/E (TTM)
—
52W range
0.00 – 0.28
Day trading desk
Gap from prior close
0.00%
Prior close 0.03
VWAP
0.02
+38.09% from price
Relative volume
0.06×
Quiet session
Session range
39.53%
0.02 – 0.03
Position in range
100%
Near session high
ATR (14D)
0.01
40.48% of price
Prior day high
0.04
PDH
Prior day low
0.02
PDL
Bid / ask spread
—
Quote not published
Session volume
17.16K
Avg 268.56K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+11.54%
+9.6%
1M
+7.41%
+6.3%
3M
-19.44%
-24.0%
6M
+45.00%
+26.8%
YTD
+11.54%
-2.7%
1Y
-81.17%
-97.6%
3Y
-96.28%
-178.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ADAPY open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+24.00K
Net buying
Buy transactions
2
231.00K shares
Sell transactions
1
207.00K shares
Net transactions
+3
Buys less sells
Sell : buy shares
0.9 : 1
Mixed
Insider-held shares
1.67M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 28, 25 | BERTRAND WILLIAM C JR Chief Operating Officer |
SELL | 207.00K | $14.26K | Direct |
| Aug 18, 25 | BEHBAHANI ALI Director |
SELL | 19.50M | $1.31M | Indirect |
| Jul 30, 25 | ECOR1 CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security |
SELL | 64.05M | $6.89M | Indirect |
| Jan 17, 25 | NORRY ELLIOT Officer |
SELL | 5.58K | $3.24K | Direct |
| Jan 17, 25 | BERTRAND WILLIAM C JR Chief Operating Officer |
SELL | 5.58K | $3.24K | Direct |
| Jan 17, 25 | RAWCLIFFE ADRIAN Chief Executive Officer |
SELL | 30.60K | $17.77K | Direct |
| Jan 17, 25 | LUNGER JOHN Officer |
SELL | 5.58K | $3.24K | Direct |
| Jan 15, 25 | PICCINA CINTIA Officer |
SELL | 12.99K | $7.47K | Direct |
| Jan 15, 25 | BERTRAND WILLIAM C JR Chief Operating Officer |
SELL | 19.54K | $11.36K | Direct |
| Jan 15, 25 | RAWCLIFFE ADRIAN Chief Executive Officer |
SELL | 59.57K | $34.64K | Direct |
| Jan 15, 25 | LUNGER JOHN Officer |
SELL | 19.54K | $11.36K | Direct |
| Jan 15, 25 | NORRY ELLIOT Officer |
SELL | 22.20K | $12.92K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BEHBAHANI ALI |
Director | — | Sale |
BERTRAND WILLIAM C JR |
Chief Operating Officer | 986.35K | Sale |
ECOR1 CAPITAL, L.L.C. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
LUNGER JOHN |
Officer | 7.51K | Sale |
NORRY ELLIOT |
Officer | 7.51K | Sale |
PICCINA CINTIA |
Officer | 18.42K | Sale |
RAWCLIFFE ADRIAN |
Chief Executive Officer | 44.33K | Sale |
Fundamentals
Market cap$7.69M
Enterprise value$-4.18M
Revenue (TTM)$5.92M
Gross profit$5.92M
EBITDA$-57.49M
Net income$-78.01M
EPS (TTM)$-0.67
Free cash flow$-61.61M
Total cash$25.95M
Total debt$14.08M
Book value / share$0.12
Shares outstanding265.05M
Float263.34M
Short % of float14.34%
Dividend yield0.00%
Beta (5Y)0.75
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book0.24
EV / revenue-0.71
EV / EBITDA0.07
Gross margin100.00%
Operating margin-1082.41%
Profit margin425.49%
Return on equity-346.65%
Return on assets-25.87%
Debt / equity44.05
Current ratio2.04
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Total revenue | $178.03M | $60.28M | $27.15M | $6.15M | +195.3% |
| Operating revenue | $178.03M | $60.28M | $27.15M | $6.15M | +195.3% |
| Cost of revenue | $70.00K | $0 | $0 | — | — |
| Gross profit | $177.96M | $60.28M | $27.15M | — | +195.2% |
| Research & development | $149.06M | $126.51M | $127.73M | $111.09M | +17.8% |
| Selling, general & admin | $81.31M | $71.81M | $63.39M | $57.30M | +13.2% |
| Total operating expense | $230.37M | $198.32M | $191.11M | $168.40M | +16.2% |
| Operating income | -$52.41M | -$138.04M | -$163.97M | -$162.25M | +62.0% |
| Net interest income | $3.25M | $5.96M | $1.54M | $1.09M | -45.5% |
| Pre-tax income | -$67.24M | -$112.53M | -$162.96M | -$157.30M | +40.3% |
| Tax provision | $3.58M | $1.34M | $2.50M | $791.00K | +167.7% |
| Net income | -$70.81M | -$113.87M | -$165.46M | -$158.09M | +37.8% |
| Net income to common | -$70.81M | -$113.87M | -$165.46M | -$158.09M | +37.8% |
| Basic EPS | -0.30 | -0.54 | -1.02 | -1.02 | +44.4% |
| Diluted EPS | -0.30 | -0.54 | -1.02 | -1.02 | +44.4% |
| EBIT | -$63.89M | -$112.53M | -$162.96M | -$162.25M | +43.2% |
| EBITDA | -$52.66M | -$102.69M | -$156.88M | -$155.68M | +48.7% |
| Basic shares | 252.30M | 201.07M | 161.21M | 155.81M | +25.5% |
| Diluted shares | 252.30M | 201.07M | 161.21M | 155.81M | +25.5% |
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $91.14M | $143.99M | $108.03M | $149.95M | -36.7% |
| Cash & short-term investments | $151.60M | $146.94M | $204.60M | $369.58M | +3.2% |
| Accounts receivable | $1.45M | $821.00K | $7.43M | $752.00K | +77.1% |
| Inventory | $7.32M | $0 | — | — | — |
| Total current assets | $188.17M | $207.55M | $255.37M | $415.46M | -9.3% |
| Property, plant & equipment | $51.22M | $71.71M | $71.53M | $51.37M | -28.6% |
| Goodwill & intangibles | $3.88M | $330.00K | $442.00K | $1.00M | +1,075.8% |
| Total assets | $245.96M | $282.62M | $328.92M | $469.55M | -13.0% |
| Total current liabilities | $64.53M | $72.79M | $64.50M | $62.54M | -11.3% |
| Long-term debt | $50.24M | — | — | — | — |
| Total debt | $74.21M | $25.23M | $23.08M | $25.47M | +194.1% |
| Total liabilities | $234.11M | $243.10M | $247.04M | $263.58M | -3.7% |
| Retained earnings | -$1.09B | -$1.02B | -$909.30M | -$743.85M | -6.9% |
| Shareholder equity | $11.85M | $39.51M | $81.88M | $205.96M | -70.0% |
| Working capital | $123.64M | $134.76M | $190.87M | $352.92M | -8.3% |
| Net tangible assets | $7.97M | $39.18M | $81.44M | $204.96M | -79.7% |
| Shares issued | 1.54B | 1.36B | 987.11M | 937.55M | +12.7% |
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Net income | -$70.81M | -$113.87M | -$165.46M | -$158.09M | +37.8% |
| Depreciation & amortisation | $11.22M | $9.84M | $6.08M | $6.57M | +14.1% |
| Stock-based compensation | $12.05M | $11.77M | $18.24M | $20.63M | +2.4% |
| Change in working capital | -$36.98M | -$24.95M | -$1.53M | $134.63M | -48.2% |
| Operating cash flow | -$73.21M | -$140.88M | -$141.77M | $10.73M | +48.0% |
| Capital expenditure | -$2.72M | -$4.88M | -$29.74M | -$8.78M | +44.3% |
| Investing cash flow | -$58.95M | $176.54M | $89.14M | $75.80M | -133.4% |
| Financing cash flow | $78.75M | $880.00K | $12.87M | $3.29M | +8,848.8% |
| Free cash flow | -$75.93M | -$145.76M | -$171.51M | $1.95M | +47.9% |
| End cash position | $93.21M | $147.02M | $109.60M | $151.67M | -36.6% |
| Line item | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|
| Total revenue | $13.68M | $7.29M | +87.7% |
| Operating revenue | $13.68M | $7.29M | +87.7% |
| Cost of revenue | $2.50M | $879.00K | +184.5% |
| Gross profit | $11.18M | $6.41M | +74.5% |
| Research & development | $22.98M | $28.86M | -20.4% |
| Selling, general & admin | $17.91M | $21.62M | -17.1% |
| Total operating expense | $40.89M | $50.48M | -19.0% |
| Operating income | -$29.72M | -$44.07M | +32.6% |
| Net interest income | -$729.00K | -$971.00K | +24.9% |
| Pre-tax income | -$29.73M | -$47.01M | +36.8% |
| Tax provision | $612.00K | $575.00K | +6.4% |
| Net income | -$30.34M | -$47.58M | +36.2% |
| Net income to common | -$30.34M | -$47.58M | +36.2% |
| Basic EPS | -0.12 | -0.18 | +33.3% |
| Diluted EPS | -0.12 | -0.18 | +33.3% |
| EBIT | -$28.77M | -$45.13M | +36.3% |
| EBITDA | -$26.26M | -$42.66M | +38.5% |
| Basic shares | 264.09M | 257.03M | +2.7% |
| Diluted shares | 264.09M | 257.03M | +2.7% |
| Line item | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|
| Cash & equivalents | $26.06M | $41.05M | -36.5% |
| Cash & short-term investments | $26.06M | $59.56M | -56.2% |
| Accounts receivable | $9.31M | $4.38M | +112.5% |
| Inventory | $11.41M | $11.76M | -3.0% |
| Total current assets | $78.11M | $103.00M | -24.2% |
| Property, plant & equipment | $46.90M | $48.94M | -4.2% |
| Goodwill & intangibles | $3.81M | $3.81M | +0.0% |
| Total assets | $130.63M | $158.07M | -17.4% |
| Total current liabilities | $51.51M | $51.07M | +0.9% |
| Long-term debt | $25.68M | $25.41M | +1.0% |
| Total debt | $48.68M | $48.71M | -0.1% |
| Total liabilities | $201.59M | $195.50M | +3.1% |
| Retained earnings | -$1.17B | -$1.14B | -2.7% |
| Shareholder equity | -$70.96M | -$37.43M | -89.6% |
| Working capital | $26.60M | $51.93M | -48.8% |
| Net tangible assets | -$74.77M | -$41.23M | -81.3% |
| Shares issued | 1.59B | 1.55B | +2.8% |
| Line item | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|
| Net income | -$30.34M | -$47.58M | +36.2% |
| Depreciation & amortisation | $2.51M | $2.47M | +1.7% |
| Stock-based compensation | $1.32M | $669.00K | +97.5% |
| Change in working capital | -$7.72M | -$21.35M | +63.8% |
| Operating cash flow | -$34.78M | -$66.59M | +47.8% |
| Capital expenditure | -$75.00K | -$1.20M | +93.8% |
| Investing cash flow | $18.49M | $41.15M | -55.1% |
| Financing cash flow | $1.65M | -$25.32M | +106.5% |
| Free cash flow | -$34.85M | -$67.80M | +48.6% |
| End cash position | $27.78M | $43.00M | -35.4% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2025 | -0.13 | -0.12 | +5.9% |
| Mar 2025 | -0.17 | -0.18 | -9.1% |
| Dec 2024 | -0.15 | -0.24 | -55.5% |
| Sep 2024 | -0.18 | -0.01 | +94.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.63%
Held by institutions0.00%
Institutions holding1
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.03
-0.00% from price
SMA 20
0.03
+6.62% from price
SMA 50
0.03
+4.17% from price
SMA 100
0.03
+4.79% from price
SMA 200
0.02
+18.71% from price
EMA 12
0.03
-0.05% from price
EMA 26
0.03
+5.37% from price
EMA 50
0.03
+6.77% from price
RSI (14)
50.9
Neutral
MACD (12,26,9)
0.00
Hist 0.00
ATR (14)
0.01
41.87% of price
Realised vol 30D
173.7%
Annualised
Bollinger upper
0.04
20, 2σ
Bollinger lower
0.02
20, 2σ
50 / 200 cross
Golden
0.03 vs 0.02
Trend bias
Above 200
+18.71%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
6.65
More volatile than market
Correlation to SPY
0.06
Largely independent
Realised vol 30D
173.7%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-99.5%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.01
41.87% of price
Beta (reported)
0.75
5Y monthly, from filing
Short interest
Shares short
31.38M
Prior 23.05M
Change vs prior
+36.1%
Shorts adding
% of float
14.34%
Elevated
% of shares out
11.84%
Against total outstanding
Days to cover
0.2
Liquid
Float
263.34M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 29, 25 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
| Jun 26, 25 | Mizuho | DOWNGRADE | Outperform | Neutral |
| May 14, 25 | Barclays | MAINTAINED | Underweight | Underweight |
| May 14, 25 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Registration Withdrawal Request
RW · 2026-04-22
Notice of termination of registration of a class of securities under Section 12(g)
15-12G · 2025-11-13
Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange
25 · 2025-10-28
Corporate Changes & Voting Matters
8-K · 2025-10-20
Corporate Changes & Voting Matters
8-K · 2025-09-26
Corporate Changes & Voting Matters
8-K · 2025-09-12
Corporate Changes & Voting Matters
8-K · 2025-09-08
Corporate Changes & Voting Matters
8-K · 2025-08-29
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.